The US Scientists Who Knew About CRISPRed Babies

Multiple researchers were aware of He Jiankui’s clinical trial before the news became public in November.

| 3 min read
a rooftop and tower at Stanford University

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

ABOVE: FLICKR, DON MCCULLOUGH

Update (March 18, 2022): STAT reports that “During the clinical trial in 2017 and 2018, [Michael] Deem regularly received data about the research subjects, including sequence data of DNA pulled from the cells of the gene-edited children, according to a source with knowledge of the project,” an assertion Deem denies through his lawyers. The outlet also reports that Rice University conducted an ethics investigation of Deem, who left the institution in the summer of 2020.

Update (February 11, 2019): MIT Technology Review reports that Stanford University is conducting an investigation "to understand what liabilities or risks" it may have in connection with the CRISPR human editing trial.

Update (January 31, 2019): STAT reports that He's former PhD advisor, Michael Deem of Rice University, was listed as the final author on a paper submitted to Nature about the CRISPR gene-editing trial.

When MIT Technology Review and the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • Shawna Williams

    Shawna was an editor at The Scientist from 2017 through 2022. She holds a bachelor's degree in biochemistry from Colorado College and a graduate certificate and science communication from the University of California, Santa Cruz.
Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo
Characterizing Immune Memory to COVID-19 Vaccination

Characterizing Immune Memory to COVID-19 Vaccination

10X Genomics
Optimize PCR assays with true linear temperature gradients

Applied Biosystems™ VeriFlex™ System: True Temperature Control for PCR Protocols

Thermo Fisher Logo

Products

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours

iStock

Agilent BioTek Cytation C10 Confocal Imaging Reader

agilent technologies logo